Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
Read more
about Skye Bioscience - 2024/03/11
$40.0 Million
Image
Skye Bioscience
PIPE
Sole Placement Agent
Read more
about Unicycive Therapeutics - 2024/03/14
$50.0 Million
Image
Unicycive Therapeutics
PIPE
Joint Placement Agent
Read more
about Aquestive Therapeutics, Inc. 2024/03/19
$75.0 Million
Image
Aquestive Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Madrigal Pharmaceuticals, Inc. - 2024/03/18
$600.0 Million
Image
Madrigal Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Praxis Precision Medicines - 2024/03/27
$200.0 Million
Image
Praxis Precision Medicines, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Boundless Bio, Inc. 2024/03/27
$100.0 Million
Image
Boundless Bio, Inc.
Initial Public Offering
Active Bookrunner
Read more
about Milestone-24-02-29
$30.0 Million
Image
Milestone Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
Read more
about Keros-2024-01-03
$161.0 Million
Image
Keros Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about CatalystPharmaceuticals-2024-01-04
$150.0 Million
Image
Catalyst Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Praxis-20234-01-11
$172.4 Million
Image
Praxis Precision Medicines
Confidentially Marketed Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 9
Next page
››
Subscribe to Biopharma